Golodnenkova V N, Bulycheva T I, Danilevich S V
Vopr Onkol. 1980;26(9):17-22.
Antibodies to soluble antigens of blast (autologous and allogeneic) and donor lymphocytes were studied in the reaction of passive hemagglutination in 44 patients with different forms of acute leukemia at the time of diagnosis, prior to chemotherapy, and in 22 healthy persons. Donors' sera did not show any antibodies while those of acute leukemia patients did in 94% of cases. It was revealed that the titre of antibodies of patients with non-lymphoblast forms of acute leukemia was statistically higher than that of patients with lymphoblast leukemia. No differences were revealed in the titres of auto- and alloblast antibodies. The antibodies mentioned belong to IgM. A correlation was observed between the titre of antibodies and IgM concentration in patients' sera. The preliminary data have demonstrated an unfavourable course of the disease in patients with high titres of antibodies.
在44例不同类型急性白血病患者诊断时、化疗前以及22名健康人的被动血凝反应中,研究了针对原始细胞(自体和异体)可溶性抗原及供体淋巴细胞的抗体。供体血清未显示任何抗体,而急性白血病患者血清在94%的病例中显示有抗体。结果表明,非淋巴细胞型急性白血病患者的抗体滴度在统计学上高于淋巴细胞白血病患者。自体和异体原始细胞抗体的滴度未显示出差异。上述抗体属于IgM。观察到患者血清中抗体滴度与IgM浓度之间存在相关性。初步数据表明,抗体滴度高的患者疾病进程不利。